1887

Journal of Medical Microbiology logo

Volume 72, Issue 1

Light Scattering Technology and MALDI-TOF MS in the microbiological fast-track of bloodstream infections: potential impact on antimicrobial treatment choices in a real-life setting No Access

Abstract

. Rapid identification (ID) and antimicrobial susceptibility testing (AST) of bloodstream infections (BSI) pathogens are fundamental to switch from empirical to targeted antibiotic therapy improving patients outcome and reducing antimicrobial resistance spreading.

. The adoption of a rapid microbiological protocol (RP) based on Matrix-Assisted Laser Desorption Ionization-Time Of Flight Mass Spectrometry (MALDI-TOF MS) and Light Scattering Technology (LST) for rapid diagnosis of BSI could positively impact on patients' antimicrobial management.

. The study aim was to evaluate a RP for BSI microbiological diagnosis in terms of accuracy, turnaround time (TAT) and potential therapeutic impact.

. A prospective observational study was conducted: monomicrobial bacterial blood cultures of septic patients were analysed in parallel by RP and standard protocol (SP). In RP the combination of MALDI-TOF MS and LST was used for rapid ID and AST assessments, respectively. To determine the potential impact of RP on antimicrobial therapy management, clinicians were interviewed on therapeutic decisions based on RP and SP results. RP accuracy, TAT and impact were evaluated in comparison to SP results.

. A total of 97 patients were enrolled. ID and AST concordance between RP and SP were 96.9 and 94.7 %, respectively. RP technical and real-life TAT were lower than SP (6.4 h vs. 18.4 h; 9.5 vs. 27.1 h). The agreement between RP- and SP-based therapeutic decisions was 90.7 (90 % CI 84.4–95.1). RP results could produce 24/97 correct antibiotic changes with 18/97 possible de-escalations and 25/97 prompt applications of infection control precautions.

. With the application of RP in BSI management, about one-fourth of patients may safely benefit from early targeted antibiotic therapy and infection control policies with one working day in advance in comparison to conventional methods. This protocol is feasible for clinical use in microbiology laboratories and potentially helpful for Antimicrobial Stewardship.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): Antimicrobial Susceptibility Testing , bloodstream infections , diagnostic stewardship , fast-track microbiology , light scattering technology and MALDI-TOF
© 2023 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001638
2023-01-09
2024-04-25
Loading full text...

Full text loading...

References

  1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315:801–810 [View Article]
     [Google Scholar]
  2. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017; 43:304–377 [View Article]
     [Google Scholar]
  3. Opota O, Croxatto A, Prod’hom G, Greub G. Blood culture-based diagnosis of bacteraemia: state of the art. Clin Microbiol Infect 2015; 21:313–322 [View Article]
     [Google Scholar]
  4. Idelevich EA, Seifert H, Sundqvist M, Scudeller L, Amit S et al. ESCMID study group for bloodstream infections, endocarditis and sepsis (ESGBIES). microbiological diagnostics of bloodstream infections in europe-an ESGBIES survey. Clin Microbiol Infect 2019; 25(11):1399–1407 [View Article]
     [Google Scholar]
  5. Giacobbe DR, Giani T, Bassetti M, Marchese A, Viscoli C et al. Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications. Clin Microbiol Infect 2020; 26:713–722 [View Article]
     [Google Scholar]
  6. Peker N, Couto N, Sinha B, Rossen JW. Diagnosis of bloodstream infections from positive blood cultures and directly from blood samples: recent developments in molecular approaches. Clin Microbiol Infect 2018; 24:944–955 [View Article]
     [Google Scholar]
  7. Straub J, Paula H, Mayr M, Kasper D, Assadian O et al. Diagnostic accuracy of the ROCHE Septifast PCR system for the rapid detection of blood pathogens in neonatal sepsis-A prospective clinical trial. PLoS One 2017; 12:e0187688 [View Article]
     [Google Scholar]
  8. She RC, Bender JM. Advances in rapid molecular blood culture diagnostics: healthcare impact, laboratory implications, and multiplex technologies. J Appl Lab Med 2019; 3:617–630 [View Article]
     [Google Scholar]
  9. Bard JD, Lee F. Why can’t we just use PCR? The role of genotypic versus phenotypic testing for antimicrobial resistance testing. Clin Microbiol Newsl 2018; 40:87–95 [View Article]
     [Google Scholar]
  10. Ellington MJ, Ekelund O, Aarestrup FM, Canton R, Doumith M et al. The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee. Clin Microbiol Infect 2017; 23:2–22 [View Article]
     [Google Scholar]
  11. Timbrook TT, Morton JB, McConeghy KW, Caffrey AR, Mylonakis E et al. The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream Infections: a systematic review and meta-analysis. Clin Infect Dis 2017; 64:15–23 [View Article]
     [Google Scholar]
  12. Pliakos EE, Andreatos N, Shehadeh F, Ziakas PD, Mylonakis E. The cost-effectiveness of rapid diagnostic testing for the diagnosis of bloodstream infections with or without antimicrobial stewardship. Clin Microbiol Rev 2018; 31:e00095-17 [View Article]
     [Google Scholar]
  13. Verroken A, Defourny L, le Polain de Waroux O, Belkhir L, Laterre P-F et al. Clinical impact of MALDI-TOF MS identification and rapid susceptibility testing on adequate antimicrobial treatment in sepsis with positive blood cultures. PLoS One 2016; 11:e0156299 [View Article]
     [Google Scholar]
  14. Dubourg G, Lamy B, Ruimy R. Rapid phenotypic methods to improve the diagnosis of bacterial bloodstream infections: meeting the challenge to reduce the time to result. Clin Microbiol Infect 2018; 24:935–943 [View Article]
     [Google Scholar]
  15. Barnini S, Brucculeri V, Morici P, Ghelardi E, Florio W et al. A new rapid method for direct antimicrobial susceptibility testing of bacteria from positive blood cultures. BMC Microbiol 2016; 16:185 [View Article]
     [Google Scholar]
  16. Giordano C, Piccoli E, Brucculeri V, Barnini S. A prospective evaluation of two rapid phenotypical antimicrobial susceptibility technologies for the diagnostic stewardship of sepsis. Biomed Res Int 2018; 2018:6976923 [View Article]
     [Google Scholar]
  17. Mantzana P, Netsika F, Arhonti M, Meletis G, Kandilioti E et al. Performance evaluation of Alfred60AST rapid susceptibility testing directly from positive blood cultures in the routine laboratory workflow. Eur J Clin Microbiol Infect Dis 2021; 40:1487–1494 [View Article]
     [Google Scholar]
  18. Boland L, Streel C, De Wolf H, Rodriguez H, Verroken A. Rapid antimicrobial susceptibility testing on positive blood cultures through an innovative light scattering technology: performances and turnaround time evaluation. BMC Infect Dis 2019; 19:989 [View Article]
     [Google Scholar]
  19. Curtoni A, Cipriani R, Marra ES, Barbui AM, Cavallo R et al. Rapid identification of microorganisms from positive blood culture by MALDI-TOF MS after short-term incubation on solid medium. Curr Microbiol 2017; 74:97–102 [View Article]
     [Google Scholar]
  20. Idelevich EA, Schüle I, Grünastel B, Wüllenweber J, Peters G et al. Rapid identification of microorganisms from positive blood cultures by MALDI-TOF mass spectrometry subsequent to very short-term incubation on solid medium. Clin Microbiol Infect 2014; 20:1001–1006 [View Article]
     [Google Scholar]
  21. Kohlmann R, Hoffmann A, Geis G, Gatermann S. MALDI-TOF mass spectrometry following short incubation on a solid medium is a valuable tool for rapid pathogen identification from positive blood cultures. Int J Med Microbiol 2015; 305:469–479 [View Article]
     [Google Scholar]
  22. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159–174 [View Article]
     [Google Scholar]
  23. Buehler SS, Madison B, Snyder SR, Derzon JH, Cornish NE et al. Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic review and meta-analysis. Clin Microbiol Rev 2016; 29:59–103 [View Article]
     [Google Scholar]
  24. Pardo J, Klinker KP, Borgert SJ, Butler BM, Giglio PG et al. Clinical and economic impact of antimicrobial stewardship interventions with the filmarray blood culture identification panel. Diagn Microbiol Infect Dis 2016; 84:159–164 [View Article]
     [Google Scholar]
  25. Bouza E, Onori R, Semiglia-Chong MA, Álvarez-Uría A, Alcalá L et al. Fast track SSTI management program based on a rapid molecular test (GeneXpert® MRSA/SA SSTI) and antimicrobial stewardship. J Microbiol Immunol Infect 2020; 53:328–335 [View Article]
     [Google Scholar]
  26. Idelevich EA, Becker K. How to accelerate antimicrobial susceptibility testing. Clin Microbiol Infect 2019; 25:1347–1355 [View Article]
     [Google Scholar]
  27. Åkerlund A, Jonasson E, Matuschek E, Serrander L, Sundqvist M et al. EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories. J Antimicrob Chemother 2020; 75:3230–3238 [View Article]
     [Google Scholar]
  28. Anton-Vazquez V, Adjepong S, Suarez C, Planche T. Evaluation of a new rapid antimicrobial susceptibility system for Gram-negative and Gram-positive bloodstream infections: speed and accuracy of Alfred 60AST. BMC Microbiol 2019; 19:268 [View Article]
     [Google Scholar]
  29. Sánchez-Carrillo C, Pescador P, Ricote R, Fuentes J, Losada C et al. Evaluation of the Alfred AST® system for rapid antimicrobial susceptibility testing directly from positive blood cultures. Eur J Clin Microbiol Infect Dis 2019; 38:1665–1670 [View Article]
     [Google Scholar]
  30. Van den Poel B, Meersseman P, Debaveye Y, Klak A, Verhaegen J et al. Performance and potential clinical impact of Alfred60AST (Alifax®) for direct antimicrobial susceptibility testing on positive blood culture bottles. Eur J Clin Microbiol Infect Dis 2020; 39:53–63 [View Article]
     [Google Scholar]
  31. Schneider JG, Wood JB, Schmitt BH, Emery CL, Davis TE et al. Susceptibility provision enhances effective de-escalation (SPEED): utilizing rapid phenotypic susceptibility testing in Gram-negative bloodstream infections and its potential clinical impact. J Antimicrob Chemother 2019; 74:i16–i23 [View Article]
     [Google Scholar]
  32. Lamy B, Sundqvist M, Idelevich EA. ESCMID study group for bloodstream infections, endocarditis and sepsis (ESGBIES). bloodstream infections - standard and progress in pathogen diagnostics. Clin Microbiol Infect 2020; 26(2):142–150 [View Article]
     [Google Scholar]
  33. Charnot-Katsikas A, Tesic V, Love N, Hill B, Bethel C et al. Use of the accelerate pheno system for identification and antimicrobial susceptibility testing of pathogens in positive blood cultures and impact on time to results and workflow. J Clin Microbiol 2018; 56:e01166-17 [View Article]
     [Google Scholar]
  34. De Angelis G, Posteraro B, Menchinelli G, Liotti FM, Spanu T et al. Antimicrobial susceptibility testing of pathogens isolated from blood culture: a performance comparison of accelerate Pheno™ and VITEK® 2 systems with the broth microdilution method. J Antimicrob Chemother 2019; 74:i24–i31 [View Article]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001638
Loading
Light Scattering Technology and MALDI-TOF MS in the microbiological fast-track of bloodstream infections: potential impact on antimicrobial treatment choices in a real-life setting
J. Med. Microbiol. 72, 001638 (2023); https://doi.org/10.1099/jmm.0.001638
/content/journal/jmm/10.1099/jmm.0.001638
/content/journal/jmm/10.1099/jmm.0.001638
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error